Treatments & Interventions
Buclizine hydrochloride
substance
Prochlorperazine edisylate
substance
Triflupromazine hydrochloride
substance
Cyclizine lactate
substance
Benzquinamide
substance
Benzquinamide hydrochloride
substance
Promethazine hydrochloride
substance
Thiethylperazine maleate
substance
Prochlorperazine maleate
substance
Trimethobenzamide hydrochloride
substance
Bromazine hydrochloride
substance
Triflupromazine
substance
Dienidol hydrochloride
substance
Ipecac syrup
substance
Thymol
substance
Chlorcyclizine
substance
Difenidol
substance
Tetrahydrocannabinol
substance
Promazine hydrochloride
substance
Hydroxyzine pamoate
substance
Clinical Trials
Recent Trials
Prophylactic Use of Naldemedine on Opioid-induced Nausea and Vomiting in Patients With Cancer: POSEIDON Study
Comparison of Remimazolam and Propofol in Endoscopic Examinations and Treatments
Akynzeo as Antiemetic Treatment in Patients With Endometrial Cancer
Ondansetron Orodispersible Film for Vomiting Prevention in Pediatric Radiotherapy
A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.
Related Conditions
Quick Facts
- SNOMED CT
- 422400008
- UMLS CUI
- C0042963
- Fully Specified Name
- Vomiting (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- Known Treatments
- 20
- Clinical Trials
- 63
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.